Haemonetics (HAE) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $72.53 -2.21%
Revenue Growth %: +2.3%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +2.3%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.44, $0.05 better than the analyst estimate of $0.39. Revenue for the quarter came in at $219.7 million versus the consensus estimate of $226.5 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- AXT appoints Tracy Liu to its board of directors
- Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
